Aptevo Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $-220 | $0 | $0 | $0 |
Gross Profit | -110 | -49 | -61 | |
EBITDA | -5,886 | -7,500 | -6,177 | -6,419 |
EBIT | -5,996 | -7,549 | -6,226 | -6,480 |
Net Income | -7,377 | -7,549 | -6,204 | -6,408 |
Net Change In Cash | -220 | 0 | 0 | 0 |
Free Cash Flow | -5,236 | -6,688 | -7,093 | -6,575 |
Cash | 21,619 | 21,061 | 9,410 | 2,139 |
Basic Shares | 3 | 224 | 41 | 4 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $3,114 |
Gross Profit | -352 | -567 | 3,114 |
EBITDA | -23,778 | -28,311 | -27,740 |
EBIT | -24,130 | -28,878 | -28,641 |
Net Income | -24,130 | -17,411 | 8,027 |
Net Change In Cash | 0 | 0 | 3,114 |
Free Cash Flow | -23,785 | -11,730 | -21,051 |
Cash | 8,714 | 16,904 | 22,635 |
Basic Shares |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$2.23 |
2025-06-30 | -$8.40 |
2025-03-31 | -$87.80 |
2024-12-31 | -$178.80 |
